Oncology Need for non-melanoma skin cancer guideline never greater Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, more than breast, bowel, and prostate cancer combined.
News Gilead claims first FDA nod for a hepatitis D therapy At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
